News | January 28, 2014

ReCor Medical Advances Ultrasound-Based Renal Denervation System

ReCor Medical Paradise System Renal Denervation RDN Therapy Hypertension
January 28, 2014 — ReCor Medical advanced its Paradise System for renal denervation (RDN) for treatment resistant hypertension (HTN).
 
The company received CE marking for the latest generation of its ultrasound-based renal denervation system. Patients were treated with the system in December 2013 at the Universitats–Herzzentrum, Bad Krozingen, Germany by Prof. Thomas Zeller, M.D. and Elias Noory, M.D.
 
"The initial procedures with the Paradise System highlighted the generator's ability to automatically customize energy delivery based on the patient's artery size while maintaining a consistent level of cooling protection," Zeller and  Noory said.
 
Drs. Nicolas Van Mieghem and Joost Daemen, Erasmus Medical Center in Rotterdam, the Netherlands, used for the first time ReCor's Radiance catheter line, which is 5 French and rapid-exchange compatible to be introduced in the radial artery.
 
"Last Friday's procedures using the new Radiance catheter with access via the radial artery marks a significant new approach to making the RDN procedure quicker, safer and potentially more cost-effective for hospitals and patients," they said. “This system's radial artery access and 10 second ablation time should allow us to treat a patient in a minimally invasive way within 30 minutes, and then let that patient go home the same day."
 
The Paradise System uses radial ultrasound as its energy source with water-based convective cooling.
 
For more information: www.recormedical.com

Related Content

News | Cath Lab | July 06, 2020
July 6, 2020 — Black patients who undergo percutaneous coronary intervention (PCI) are at an increased risk for major
TCT cancels in-person meeting and goes virtual due to COVID-19
News | Cath Lab | May 27, 2020
May 27, 2020 — To ensure the health and safety of all attendees due to the ongoing COVID-19 (SARS-CoV-2) pandemic, th
Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or nil per os (NPO), as there are no current standardized fasting protocols, but the CHOWNOW study found patients do not need to fast and will have similar outcomes. #SCAI2020
Feature | Cath Lab | May 18, 2020
May 18, 2020 – Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, o
Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiography and Interventions (SCAI) and chief, Division of Cardiovascular Medicine at UC San Diego Medical Center,
Podcast | Cath Lab | May 13, 2020
This podcast is an interview with Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiograp
Nuance Communications Inc. introduced Nuance Cardiovascular CAPD, a new computer-assisted physician documentation (CAPD) solution designed to help cardiologists improve the quality of complex documentation and the accuracy of reimbursement for cardiac catheterization procedures. The Nuance Cardiovascular CAPD solution is available through a partnership with ZHealth for this solution, which is based on patented algorithms built with ZHealth’s interventional documentation and coding expertise.
News | Cath Lab | January 31, 2020
January 29, 2020 – Nuance Communications Inc.
Videos | Cath Lab | January 09, 2020
Haval Chweich, M.D., medical director of the cardiac critical care unit (CCU) at Tufts Medical Center, and assistant...